Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01532817 · ClinicalTrials.gov registry record · NA
Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Device
A NA study, sponsored by ElectroCore.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01532817 is a NA study that has completed, run by ElectroCore. The registered enrollment target is 30 participants.
The verdict
NCT01532817, a NA study, has completed, sponsored by ElectroCore.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to collect preliminary clinical data related to the safety and preliminary clinical benefits of non-invasive vagal nerve stimulation with the AlphaCore™ device for the relief of acute bronchoconstriction due to asthma. Up to 30 subjects who meet all inclusion/exclusion criteria and consent to participate in the study may be enrolled at up to 5 investigational (study) sites. The study sites are clinic settings capable of treating any potential complications of bronchoconstriction, an acute exacerbation of asthma, and any emergencies associated with use of the investigational device.
Interventions
- DEVICE AlphaCore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01532817
The ClinicalTrials.gov registry entry for NCT01532817 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ElectroCore, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AlphaCore is the first listed.
NCT01532817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01532817 about?
NCT01532817 is a clinical study titled "Relief of Acute Bronchoconstriction/Asthma Using the Non-Invasive AlphaCore Device". The purpose of this pilot study is to collect preliminary clinical data related to the safety and preliminary clinical benefits of non-invasive vagal nerve stimulation with the AlphaCore™ device for the relief of acute bronchoconstriction due to asthma. Up to 30 subjects who meet all inclusion/excl...
What is the current status of trial NCT01532817?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2012-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01532817?
The interventions under investigation include: AlphaCore (DEVICE).
Who is sponsoring clinical trial NCT01532817?
This trial is sponsored by ElectroCore, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.